{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:22:58Z","timestamp":1788992578849,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","award":["F\/27\/23"],"award-info":[{"award-number":["F\/27\/23"]}],"id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["413517907"],"award-info":[{"award-number":["413517907"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005970","name":"Deutsche Stiftung f\u00fcr Herzforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002714","name":"Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021729","name":"Medizinische Fakult\u00e4t der Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","award":["HI1573\/2"],"award-info":[{"award-number":["HI1573\/2"]}],"id":[{"id":"10.13039\/501100021729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021729","name":"Medizinische Fakult\u00e4t der Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","award":["HI1573\/10"],"award-info":[{"award-number":["HI1573\/10"]}],"id":[{"id":"10.13039\/501100021729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021729","name":"Medizinische Fakult\u00e4t der Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","award":["HI1573\/9"],"award-info":[{"award-number":["HI1573\/9"]}],"id":[{"id":"10.13039\/501100021729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.atherosclerosis.2025.119239","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T10:56:56Z","timestamp":1747133816000},"page":"119239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Experimental evidence on colchicine's mode of action in human carotid artery plaques"],"prefix":"10.1016","volume":"406","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-321X","authenticated-orcid":false,"given":"Alexander","family":"von Ehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines Derya","family":"Steenbuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"H\u00e4fele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Remmersmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara A.","family":"Vico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Ehlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Tholen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Czerny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Hilgendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.119239_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global impact of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4330\/wjc.v9.i2.76","article-title":"PCSK9 inhibitors: a new era of lipid lowering therapy","volume":"9","author":"Chaudhary","year":"2017","journal-title":"World J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00395-020-00838-4","article-title":"Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering","volume":"115","author":"H\u00e4rdtner","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving Statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib7","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.865367","article-title":"Macrophages in atheromatous plaque developmental stages","volume":"9","author":"von Ehr","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCRESAHA.120.315936","article-title":"Modifiable cardiovascular risk, hematopoiesis and innate immunity","volume":"126","author":"Schloss","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11883-012-0274-8","article-title":"Making a difference: Monocyte heterogeneity in cardiovascular disease","volume":"14","author":"Hilgendorf","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2023.03.006","article-title":"A comparative gene expression matrix in Apoe-deficient mice identifies unique and atherosclerotic disease stage-specific gene regulation patterns in monocytes and macrophages","volume":"371","author":"H\u00e4rdtner","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10067-022-06402-w","article-title":"Efficacy and safety of colchicine for the treatment of osteoarthritis: a systematic review and meta-analysis of intervention trials","volume":"42","author":"Singh","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2023.01.034","article-title":"Effect of colchicine on recurrent serositis in familial mediterranean fever","author":"Suzuki","year":"2023","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib15","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clinthera.2023.01.004","article-title":"The role of colchicine in different clinical phenotypes of behcet disease","volume":"45","author":"Wang","year":"2023","journal-title":"Clin Ther"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/cei.13664","article-title":"Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Beh\u00e7et\u2019s syndrome","volume":"206","author":"Bettiol","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib18","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib19","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102835","article-title":"Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials","volume":"76","author":"Fiolet","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease","volume":"135","author":"Robinson","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib23","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib24","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib25","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib27","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.1111\/jcmm.16798","article-title":"Anti\u2010inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib28","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201469R","article-title":"Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation","volume":"37","author":"Schwarz","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1189\/jlb.1012510","article-title":"Technical advance: inhibition of neutrophil chemotaxis by colchicine is modulated through viscoelastic properties of subcellular compartments","volume":"94","author":"Paschke","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.898690","article-title":"Colchicine impacts leukocyte trafficking in atherosclerosis and reduces vascular inflammation","volume":"13","author":"Meyer-Lindemann","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/pharmaceutics14071395","article-title":"The role of colchicine in atherosclerosis: from bench to bedside","volume":"14","author":"Gonz\u00e1lez","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib32","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/ijms24032483","article-title":"Colchicine in athero-thrombosis: molecular mechanisms and clinical evidence","volume":"24","author":"Cimmino","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib33","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib34","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/ac0262560","article-title":"Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS\/MS","volume":"75","author":"Thompson","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biochi.2015.10.009","article-title":"Impact of cathepsin B on the interstitial fluid proteome of murine breast cancers","volume":"122","author":"Gomez-Auli","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib37","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-Sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00018-022-04584-9","article-title":"Proteome alterations during clonal isolation of established human pancreatic cancer cell lines","volume":"79","author":"Bernhard","year":"2022","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/clpt.1993.161","article-title":"Colchicine disposition in human leukocytes after single and multiple oral administration","volume":"54","author":"Chappey","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib40","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/j.1552-4604.1996.tb04753.x","article-title":"Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses","volume":"36","author":"Ferron","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib42","first-page":"2879","article-title":"A role for IL-18 in neutrophil activation","volume":"167","author":"Leung","year":"1950","journal-title":"J. Immunol. Baltim. Md"},{"issue":"03.560632","key":"10.1016\/j.atherosclerosis.2025.119239_bib43","article-title":"Colchicine promotes atherosclerotic plaque stability independently of inflammation","volume":"10","author":"Li","year":"2023"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvq046","article-title":"Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis","volume":"86","author":"Madrigal-Matute","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/ATVBAHA.123.319177","article-title":"OTUB1 catalytic-independently deubiquitinates TGFBI and mediates the angiogenesis in infantile hemangioma by regulating glycolysis","volume":"43","author":"Li","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.ATV.21.1.47","article-title":"Cartilage oligomeric matrix protein (thrombospondin-5) is expressed by human vascular smooth muscle cells","volume":"21","author":"Riessen","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCRESAHA.115.308021","article-title":"Shift of macrophage phenotype due to cartilage oligomeric matrix protein deficiency drives atherosclerotic calcification","volume":"119","author":"Fu","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib48","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00395-016-0535-8","article-title":"Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression","volume":"111","author":"Lindau","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib50","doi-asserted-by":"crossref","unstructured":"Angelidis, C. et al. Colchicine pharmacokinetics and mechanism of action. Curr Pharm Des 24, 659\u2013663.","DOI":"10.2174\/1381612824666180123110042"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10753-015-0237-7","article-title":"Effect of colchicine on platelet-platelet and platelet-leukocyte interactions: a pilot study in healthy subjects","volume":"39","author":"Shah","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib53","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1517\/17425255.2014.915027","article-title":"Pharmacokinetics considerations for gout treatments","volume":"10","author":"Richette","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin. Toxicol. Phila. Pa"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib56","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-Four\u2013Hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijcard.2017.03.126","article-title":"Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model","volume":"240","author":"Akodad","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib58","first-page":"1174","article-title":"Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction","volume":"81","author":"Fujisue","year":"2017","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib59","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","article-title":"Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease","volume":"142","author":"Opstal","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib61","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI200112455","article-title":"The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation","volume":"108","author":"Cuff","year":"2001","journal-title":"J Clin Investig"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11883-020-00870-8","article-title":"CD36 in atherosclerosis: pathophysiological mechanisms and therapeutic implications","volume":"22","author":"Tian","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00011-022-01540-y","article-title":"Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation","volume":"71","author":"Bonaventura","year":"2022","journal-title":"Inflamm Res"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib64","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib65","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.024","article-title":"Expression of the NLRP3 inflammasome in carotid atherosclerosis","volume":"24","author":"Shi","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib66","doi-asserted-by":"crossref","unstructured":"Paramel Varghese, G. et al. NLRP3 inflammasome expression and activation in human atherosclerosis. J Am Heart Assoc 5, e003031.","DOI":"10.1161\/JAHA.115.003031"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12964-023-01356-1","article-title":"P2X7 receptor activation leads to NLRP3-independent IL-1\u03b2 release by human macrophages","volume":"21","author":"Bockstiegel","year":"2023","journal-title":"Cell Commun. Signal. CCS"},{"issue":"72","key":"10.1016\/j.atherosclerosis.2025.119239_bib68","first-page":"29","article-title":"Neutrophils use a novel NLRP3 inflammasome-independent mechanism to release bioactive IL-1\u03b2 in response to lysosomal disruption","volume":"210","author":"Miller","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib69","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1073\/pnas.96.11.6261","article-title":"Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3","volume":"96","author":"Coeshott","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib70","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1002\/art.24959","article-title":"Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation","volume":"60","author":"Guma","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12860-020-00309-7","article-title":"Platelet adhesion and aggregate formation controlled by immobilised and soluble VWF","volume":"21","author":"Schneider","year":"2020","journal-title":"BMC Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib72","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V88.7.2569.bloodjournal8872569","article-title":"Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen","volume":"88","author":"Godyna","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1538-7836.2003.00063.x","article-title":"Fibrinogen \u03b3 chain functions","volume":"1","author":"Mosesson","year":"2003","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002641","article-title":"Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling","volume":"8","author":"Bradley","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib75","article-title":"MMP-12 polarizes neutrophil signalome towards an apoptotic signature","volume":"264","author":"Chalise","year":"2022","journal-title":"J Proteonomics"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109100","article-title":"Collagen VI antibody reduces atherosclerosis by activating monocyte\/macrophage polarization in ApoE-\/- mice","volume":"111","author":"Liu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.119239_bib77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/1570161115666170201121232","article-title":"Cartilage oligomeric matrix protein: matricellular and matricrine signaling in cardiovascular homeostasis and disease","volume":"15","author":"Fu","year":"2017","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025001376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025001376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:21:59Z","timestamp":1778473319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025001376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":77,"alternative-id":["S0021915025001376"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119239","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental evidence on colchicine's mode of action in human carotid artery plaques","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119239"}}